Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;32(9):488-93.
doi: 10.5732/cjc.012.10280. Epub 2013 Jan 18.

Small interfering RNA-based molecular therapy of cancers

Wei Guo  1 , Wangbing Chen, Wendan Yu, Wenlin Huang, Wuguo Deng
Affiliations
Review

Small interfering RNA-based molecular therapy of cancers

Wei Guo et al. Chin J Cancer. 2013 Sep.

Abstract

RNA interference (RNAi) has become a gold standard for validating gene function in basic life science research and provides a promising therapeutic modality for cancer and other diseases. This mini-review focuses on the potential of small interfering RNAs (siRNAs) in anticancer treatment, including the establishment and screening of cancer-associated siRNA libraries and their applications in anticancer drug target discovery and cancer therapy. This article also describes the current delivery approaches of siRNAs using lipids, polymers, and, in particular, gold nanoparticles to induce significant gene silencing and tumor growth regression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Mechanism of RNA interference
See this image and copyright information in PMC

References

    1. Xie W, Liang C, Birchler JA. Inhibition of RNA interference and modulation of transposable element expression by cell death in Drosophila. Genetics. 2011;188:823–834. - PMC - PubMed
    1. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498. - PubMed
    1. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 2004;432:173–178. - PubMed
    1. Jagani H, Rao JV, Palanimuthu VR, et al. A nanoformulation of siRNA and its role in cancer therapy: in vitro and in vivo evaluation. Cell Mol Biol Lett. 2013;18:120–136. - PMC - PubMed
    1. De Fougerolles A, Vornlocher HP, Maraganore J, et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007;6:443–453. - PMC - PubMed